Hemodynamics in Coronary Artery Bypass Surgery: Effects of Intraoperative Dexmedetomidine Administration

Overview

Journal Anaesthesist

Specialty Anesthesiology

Date 2011 Jan 29

PMID 21271232

Citations 14

Authors

H Karakaya Kabukcu

N Sahin

Y Temel

T Aydogdu Titiz

Affiliations

Soon will be listed here.

Abstract

Objective: Dexmedetomidine is an α2-receptor agonist which is increasingly being used in coronary artery bypass grafting (CABG) surgery due to its suppressive effect on the stress responses against intubation and surgery. In this study effects of dexmedetomidine administration as an adjuvant agent during induction and maintenance of anesthesia on intraoperative hemodynamic changes were studied in patients undergoing CABG.

Methods: A total of 20 patients undergoing CABG were included in the study. At the beginning dexmedetomidine infusion of 1 µg/kg body weight (BW)/h was performed for 10 min. After this the infusion dosage of dexmedetomidine was decreased to 0.2-0.4 µg/kgBW/h, 0.15 mg/kgBW of cisatracurium was administered for intubation and 0.5 MAC (minimum alveolar concentration) sevoflurane was administered as a volatile anesthetic. Heart rate (HR), mean arterial pressure (MAP), mean pulmonary artery pressure (MPAP), cardiac output (CO), systemic vascular resistance (SVR) and pulmonary vascular resistance (PVR) were recorded 10 min after dexmedetomidine infusion, following intubation, during skin incision and sternotomy, before and after the bypass and in the postoperative period.

Results: With dexmedetomidine infusion HR and MAP were found to be moderately decreased in comparison to baseline values and no severe bradycardia or hypotension requiring intervention occurred. No increase in HR and MAP values were recorded during sternotomy and bypass. The MPAP evaluation showed no difference between the preoperative and intraoperative values (p>0.05). The cardiac output (CO) was found to be low starting from the time of skin incision to just before the bypass, compared to preoperative values (p<0.05) and SVR was moderately decreased with initial high dose infusion and after that increased to baseline values (p<0.05).

Conclusion: Dexmedetomidine can be safely used in CABG operations delivering a stable hemodynamic status throughout the operative period.

Citing Articles

The efficacy of dexmedetomidine for septic shock: A meta-analysis of randomized controlled trials.

Huang X, He C Medicine (Baltimore). 2023; 102(35):e34414.

PMID: 37657031 PMC: 10476718. DOI: 10.1097/MD.0000000000034414.

Comparative Evaluation of Dexmedetomidine and Magnesium Sulfate for Prevention of Postoperative Atrial Fibrillation in Patients of Coronary Artery Bypass Surgeries.

Jadhav J, Mankhair S, Chakole V Cureus. 2023; 15(6):e41075.

PMID: 37519545 PMC: 10375826. DOI: 10.7759/cureus.41075.

Comparison between dexmedetomidine and propofol on outcomes after coronary artery bypass graft surgery: a retrospective study.

Hu J, Lv B, West R, Chen X, Yan Y, Soo C BMC Anesthesiol. 2022; 22(1):51.

PMID: 35183122 PMC: 8857833. DOI: 10.1186/s12871-022-01589-6.

Impact of intravenous dexmedetomidine on postoperative bowel movement recovery after laparoscopic nephrectomy: A consort-prospective, randomized, controlled trial.

Huang S, Song F, Yang S, Hu S, Zhao L, Wang S World J Clin Cases. 2021; 9(26):7762-7771.

PMID: 34621826 PMC: 8462239. DOI: 10.12998/wjcc.v9.i26.7762.

Cardiac Preconditioning Effect of Ketamine-Dexmedetomidine versus Fentanyl-Propofol during Arrested Heart Revascularization.

Hegazy M, Hegazi R, Hendawy S, Hussein M, Abdellateef A, Awad G Anesth Essays Res. 2021; 14(2):312-320.

PMID: 33487835 PMC: 7819405. DOI: 10.4103/aer.AER_55_20.

References

Menda F, Koner O, Sayin M, Ture H, Imer P, Aykac B . Dexmedetomidine as an adjunct to anesthetic induction to attenuate hemodynamic response to endotracheal intubation in patients undergoing fast-track CABG. Ann Card Anaesth. 2010; 13(1):16-21. DOI: 10.4103/0971-9784.58829. View

Ebert T, Hall J, BARNEY J, Uhrich T, Colinco M . The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 2000; 93(2):382-94. DOI: 10.1097/00000542-200008000-00016. View

STOELTING R . Attenuation of blood pressure response to laryngoscopy and tracheal intubation with sodium nitroprusside. Anesth Analg. 1979; 58(2):116-9. View

Mikawa K, Obara H, Kusunoki M . Effect of nicardipine on the cardiovascular response to tracheal intubation. Br J Anaesth. 1990; 64(2):240-2. DOI: 10.1093/bja/64.2.240. View

Bhana N, Goa K, McClellan K . Dexmedetomidine. Drugs. 2000; 59(2):263-8; discussion 269-70. DOI: 10.2165/00003495-200059020-00012. View

Huiku M, Uutela K, Van Gils M, Korhonen I, Kymalainen M, Merilainen P . Assessment of surgical stress during general anaesthesia. Br J Anaesth. 2007; 98(4):447-55. DOI: 10.1093/bja/aem004. View

Hall J, Uhrich T, Ebert T . Sedative, analgesic and cognitive effects of clonidine infusions in humans. Br J Anaesth. 2001; 86(1):5-11. DOI: 10.1093/bja/86.1.5. View

Mikawa K, Nishina K, Maekawa N, Obara H . Comparison of nicardipine, diltiazem and verapamil for controlling the cardiovascular responses to tracheal intubation. Br J Anaesth. 1996; 76(2):221-6. DOI: 10.1093/bja/76.2.221. View

Wijeysundera D, Naik J, Beattie W . Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. Am J Med. 2003; 114(9):742-52. DOI: 10.1016/s0002-9343(03)00165-7. View

10.

Yuan L, Chia Y, Jan K, Chen C, Wang C, Haung L . The effect of single bolus dose of esmolol for controlling the tachycardia and hypertension during laryngoscopy and tracheal intubation. Acta Anaesthesiol Sin. 1994; 32(3):147-52. View

11.

Charuluxananan S, Kyokong O, Somboonviboon W, Balmongkon B, Chaisomboonpan S . Nicardipine versus lidocaine for attenuating the cardiovascular response to endotracheal intubation. J Anesth. 2003; 14(2):77-81. DOI: 10.1007/s005400050071. View

12.

Herr D, Sum-Ping S, England M . ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth. 2003; 17(5):576-84. DOI: 10.1016/s1053-0770(03)00200-3. View

13.

Jalonen J, Hynynen M, Kuitunen A, Heikkila H, Perttila J, Salmenpera M . Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology. 1997; 86(2):331-45. DOI: 10.1097/00000542-199702000-00009. View

14.

Bloor B, FRANKLAND M, Alper G, Raybould D, Weitz J, Shurtliff M . Hemodynamic and sedative effects of dexmedetomidine in dog. J Pharmacol Exp Ther. 1992; 263(2):690-7. View

15.

Kunisawa T, Nagata O, Nagashima M, Mitamura S, Ueno M, Suzuki A . Dexmedetomidine suppresses the decrease in blood pressure during anesthetic induction and blunts the cardiovascular response to tracheal intubation. J Clin Anesth. 2009; 21(3):194-9. DOI: 10.1016/j.jclinane.2008.08.015. View

16.

Desborough J . The stress response to trauma and surgery. Br J Anaesth. 2000; 85(1):109-17. DOI: 10.1093/bja/85.1.109. View

17.

Singh H, Vichitvejpaisal P, Gaines G, White P . Comparative effects of lidocaine, esmolol, and nitroglycerin in modifying the hemodynamic response to laryngoscopy and intubation. J Clin Anesth. 1995; 7(1):5-8. DOI: 10.1016/0952-8180(94)00013-t. View

18.

Ko S, Kim D, Han Y, Song H . Small-dose fentanyl: optimal time of injection for blunting the circulatory responses to tracheal intubation. Anesth Analg. 1998; 86(3):658-61. DOI: 10.1097/00000539-199803000-00041. View

19.

Venn R, Grounds R . Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. Br J Anaesth. 2002; 87(5):684-90. DOI: 10.1093/bja/87.5.684. View